Non-Expert Access Enable researchers with limited bioinformatics to perform data-driven translational research, accelerating target discovery and safety assessment. Target buyers include biotech startups, academic labs, and CROs who need rapid, credible insights without in-house data science. Offer a low-friction pilot and onboarding to demonstrate ROI and shorten time to first insight.

Integrated Knowledge Graph Highlight the platform's expansive knowledge graph that aggregates literature, patents, clinical and multi-omics data to surface novel targets and rationales for development decisions. Position Euretos as a tool for evidence synthesis and hypothesis generation for mid-size pharma and contract research organizations that require comprehensive data without building internal pipelines. Demonstrate AI-predicted gene-disease associations to support proposals and grant work.

Funding Partnerships Capitalize on recent grant funding and consortia activity to pursue funded collaborations. Propose joint grant opportunities or sponsored projects with Euretos as the data and analytics partner, offering access to workflows and validation support for predictive personalized treatment studies.

Workflow Expansion Leverage ongoing product expansions such as single-cell study viewer and orthologs and similar proteins workflows to broaden addressable disease areas, particularly oncology and translational research. Upsell premium analytics modules and custom workflows, plus professional services for tailored study design and evidence gathering.

Market Strategy Position Euretos as a nimble EU-facing partner with potential for channel partnerships and university collaborations. Target mid-market biotech firms, CROs, and academic groups with rapid demos, pilot projects, and co-marketing to accelerate uptake in translational research, pharmacovigilance, and clinical trial design.